{"Q": 1, "answer": "no", "rationale": "The segment does not contain an intensifier or comparative adjective directly modifying a risk-adjective.", "method": "llm_batch", "batch_id": "batch_1_10948", "batch_size": 200, "batch_pos": 15, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 2, "answer": "no", "rationale": "The segment contains no high-potency verbs, metaphors, or critical alert phrases.", "method": "llm_batch", "batch_id": "batch_2_15696", "batch_size": 200, "batch_pos": 197, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 3, "answer": "no", "rationale": "Describes quantities of doses, not impact with a moderate verb.", "method": "llm_batch", "batch_id": "batch_3_10336", "batch_size": 200, "batch_pos": 152, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"hop_idx": 4, "answer": "uncertain", "rationale": "Missing response from batch", "method": "fallback", "batch_id": "batch_4_18176", "batch_size": 200, "batch_pos": 150, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 4, "answer": "uncertain", "rationale": "LLM call failed.", "method": "llm_batch_retry", "retry": 1, "batch_id": "batch_4_18176_r1", "batch_size": 200, "batch_pos": 150, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 5, "answer": "no", "rationale": "The segment reports factual information about a deal but contains no explicit calming language.", "method": "llm_batch", "batch_id": "batch_5_8436", "batch_size": 200, "batch_pos": 148, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"hop_idx": 6, "answer": "uncertain", "rationale": "Missing response from batch", "method": "fallback", "batch_id": "batch_6_18488", "batch_size": 200, "batch_pos": 119, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 6, "answer": "no", "rationale": "No minimiser or scale contrast found.", "method": "llm_batch_retry", "retry": 1, "batch_id": "batch_6_18488_r1", "batch_size": 200, "batch_pos": 119, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 7, "answer": "no", "rationale": "Segment does not contain a bare negation.", "method": "llm_batch", "batch_id": "batch_7_17904", "batch_size": 200, "batch_pos": 105, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 8, "answer": "yes", "rationale": "Describes capability/preparedness ('secures up to 665,000 doses', 'includes an option for a further 40 million vaccines') without explicit calming keywords.", "method": "llm_batch", "batch_id": "batch_8_18968", "batch_size": 200, "batch_pos": 161, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
